ConductScience.org, home

Paper39201255

An Overview of Altered Pathways Associated with Sensitivity to Platinum-Based Chemotherapy in Neuroendocrine Tumors: Strengths and Prospects.

Stefàno E and 6 others. Int J Mol Sci, 2024. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. An Overview of Altered Pathways Associated with Sensitivity to Platinum-Based Chemotherapy in Neuroendocrine Tumors: Strengths and Prospects. Papers, record 39201255. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39201255

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
An Overview of Altered Pathways Associated with Sensitivity to Platinum-Based Chemotherapy in Neuroendocrine Tumors: Strengths and Prospects.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
1.75, provisional
iCite
Revised in PubMed
2024-09-03
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Stefàno EErika
2De Castro FFedericahttps://orcid.org/0000-0001-5060-293X
3Ciccarese AAntonella
4Muscella AAntonellahttps://orcid.org/0000-0002-2822-9929
5Marsigliante SSantohttps://orcid.org/0000-0001-6535-3286
6Benedetti MMichelehttps://orcid.org/0000-0001-9936-9649
7Fanizzi FPFrancesco Paolohttps://orcid.org/0000-0003-3073-5772

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Neuroendocrine TumorsMajor topic
Humans
Antineoplastic Agents
Carboplatin
Cisplatin
Signal Transduction
Antineoplastic Combined Chemotherapy Protocols
Platinum
DNA Repair

Source PubMed

Download CSV of topics

References229

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128161703Neuroendocrine Cancer, Therapeutic Strategies in G3 Cancers.Digestion2017https://conductscience.org/library/papers/28161703PubMed
227816207Loss of DPC4/SMAD4 expression in primary gastrointestinal neuroendocrine tumors is associated with cancer-related death after resection.Surgery2017https://conductscience.org/library/papers/27816207PubMed
328497778PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3.Nat Commun2017https://conductscience.org/library/papers/28497778PubMed
426251638Etoposide induces cell death via mitochondrial-dependent actions of p53.Cancer Cell Int2015https://conductscience.org/library/papers/26251638PubMed
58805928Superiority of cisplatin or carboplatin in combination with teniposide and vincristine in the induction chemotherapy of small-cell lung cancer. A randomized trial with 5 years follow up.Ann Oncol1996https://conductscience.org/library/papers/8805928PubMed
620407018Focal adhesion kinase, a downstream mediator of Raf-1 signaling, suppresses cellular adhesion, migration, and neuroendocrine markers in BON carcinoid cells.Mol Cancer Res2010https://conductscience.org/library/papers/20407018PubMed
714576837Cisplatin: mode of cytotoxic action and molecular basis of resistance.Oncogene2003https://conductscience.org/library/papers/14576837PubMed
831098602Unexpected therapeutic effects of cisplatin.Metallomics2019https://conductscience.org/library/papers/31098602PubMed
923042098MAPK signaling in cisplatin-induced death: predominant role of ERK1 over ERK2 in human hepatocellular carcinoma cells.Carcinogenesis2013https://conductscience.org/library/papers/23042098PubMed
1026703889Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study.Lancet2016https://conductscience.org/library/papers/26703889PubMed
1123239809Synergistic effect of olaparib with combination of cisplatin on PTEN-deficient lung cancer cells.Mol Cancer Res2013https://conductscience.org/library/papers/23239809PubMed
1230968324Notch pathway in small-cell lung cancer: from preclinical evidence to therapeutic challenges.Cell Oncol (Dordr)2019https://conductscience.org/library/papers/30968324PubMed
1325837868The p53 network as therapeutic target in gastroenteropancreatic neuroendocrine neoplasms.Cancer Treat Rev2015https://conductscience.org/library/papers/25837868PubMed
1422343668Signaling pathways as specific pharmacologic targets for neuroendocrine tumor therapy: RET, PI3K, MEK, growth factors, and Notch.Neuroendocrinology2013https://conductscience.org/library/papers/22343668PubMed
1531652074177Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumors.Expert Rev Gastroenterol Hepatol2019https://conductscience.org/library/papers/31652074PubMed
1633643409Detection of Genetic Mutations by Next-Generation Sequencing for Predicting Prognosis of Extensive-Stage Small-Cell Lung Cancer.J Oncol2020https://conductscience.org/library/papers/33643409PubMed
1717522241Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors.Oncologist2007https://conductscience.org/library/papers/17522241PubMed
184176152Treatment of multiple-hormone-producing malignant islet-cell tumour with streptozotocin.Lancet1968https://conductscience.org/library/papers/4176152PubMed
1928351033ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents.Neuroendocrinology2017https://conductscience.org/library/papers/28351033PubMed
2029566943P16 is a useful supplemental diagnostic marker of pulmonary small cell carcinoma in small biopsies and cytology specimens.Ann Diagn Pathol2018https://conductscience.org/library/papers/29566943PubMed

See all 229 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42014876Chidamide synergizes with cisplatin-etoposide to trigger pyroptosis and anti-tumor immunity in diffuse large B-cell lymphoma.Commun Med (Lond)2026https://conductscience.org/library/papers/42014876PubMed
41658779Neuroendocrine Neoplasms of the Gastrointestinal Tract: Morphology, WHO 2022 Grading, and Prognostic Perspectives.Cureus2026https://conductscience.org/library/papers/41658779PubMed
41449180Decoding the molecular mechanism via systems biology-based insights into neoschaftoside from Ailanthus altissima targeting lung cancer.Sci Rep2025https://conductscience.org/library/papers/41449180PubMed
41011719The Role of Metallodrugs in Enhancing Neuroendocrine Neoplasm Therapies: The Promising Anticancer Potential of Ruthenium-Based Complexes.Molecules2025https://conductscience.org/library/papers/41011719PubMed
40429384Treatment of Pancreatic Neuroendocrine Tumors: Beyond Traditional Surgery and Targeted Therapy.J Clin Med2025https://conductscience.org/library/papers/40429384PubMed
40217714Clinicopathological Characteristics of Extrapulmonary Neuroendocrine Carcinomas: Treatment Responses and Survival Outcomes: Single-Center Experience.J Clin Med2025https://conductscience.org/library/papers/40217714PubMed
39502104Prognostic Expression Signature of RB1, PTEN, and TP53 Genes in Patients with Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors.Eur Urol Open Sci2024https://conductscience.org/library/papers/39502104PubMed
39339356Metal-Based Drug-DNA Interactions and Analytical Determination Methods.Molecules2024https://conductscience.org/library/papers/39339356PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
MDM24193PubTator's text mininghttps://conductscience.org/library/genes/4193NCBI Gene
PTEN5728PubTator's text mininghttps://conductscience.org/library/genes/5728NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39201255

GET https://conductscience.org/api/papers/v1/39201255/references?page=2